Alzheimer’s Research UK partners with global leaders including Bill Gates to revolutionise detection of neurodegenerative diseases

Alzheimer’s Research UK, the UK’s leading dementia research charity, has partnered with global leaders, including Bill Gates, to advance the charity’s Early Detection of Neurodegenerative diseases (EDoN) initiative. The global initiative, which aims to develop a digital device to radically improve the detection of diseases that cause dementia, aims to secure at least £67million over its first six years. The initiative with funding from Bill Gates and others, will be overseen by a new Board of 10 prominent experts, led by former UK Prime Minister and President of Alzheimer’s Research…

Read More

Bill Gates announces investment to improve Alzheimer’s diagnosis

Leading philanthropist Bill Gates has announced that he is to invest in a new fund designed to bring about improved diagnosis of Alzheimer’s disease, the most common cause of dementia. Mr Gates made his first investment into dementia research in November 2017 when he put $50m into the Dementia Discovery Fund (DDF), which provides backing for early-stage drug discovery projects around the globe. The DDF was formed through a collaboration of the UK Department of Health, Alzheimer’s Research UK and several leading pharmaceutical companies. Today’s announcement sees Mr Gates make…

Read More

Dementia Discovery Fund attracts $50 million investment from Bill Gates

The Dementia Discovery Fund (DDF) today announces a $50 million investment from Bill Gates. The investment is Gates’ first to accelerate progress toward disease-modifying therapies for Alzheimer’s disease. Mr Gates made the announcement on his blog. The DDF, managed by SV Health, is a unique venture fund focused entirely on discovering and developing novel therapies for dementia and was formed through the collaboration of leading pharmaceutical companies, the UK Department of Health and the charity Alzheimer’s Research UK (ARUK). Since its launch in October 2015, the DDF has made significant…

Read More